Resting haemodynamics, exercise parameters, and pulmonary function data for the study population
| Characteristics . | No COPD–no HF (Group 1) . | COPD–no HF (Group 2) . | HF–no COPD (Group 3) . | COPD–HF (Group 4) . |
|---|---|---|---|---|
| Baseline parameters | ||||
| HR (b.p.m.) | 72.30 ± 0.23 | 72.36 ± 0.46 | 71.90 ± 0.48 | 73.61 ± 1.09 |
| SBP (mmHg) | 124.77 ± 0.30 | 125.67 ± 0.59 | 120.33 ± 0.62 | 118.08 ± 1.40 |
| DBP (mmHg) | 78.16 ± 0.18 | 77.20 ± 0.36 | 75.25 ± 0.39 | 74.17 ± 0.94 |
| Pulmonary parameters | ||||
| FEV1 (L) | 3.06 ± 0.01 | 2.50 ± 0.02 | 2.85 ± 0.02 | 2.17 ± 0.05 |
| FVC (L) | 3.78 ± 0.01 | 3.93 ± 0.03 | 3.53 ± 0.03 | 3.36 ± 0.06 |
| FEV1/FVC (%) | 0.809 ± 0.001 | 0.638 ± 0.002 | 0.809 ± 0.002 | 0.640 ± 0.005 |
| Exercise parameters | ||||
| ET (min) | 9.47 ± 0.06 | 8.94 ± 0.13 | 9.67 ± 0.10 | 8.89 ± 0.23 |
| VT (mL/min/kg) | 15.15 ± 0.10 | 15.04 ± 0.20 | 16.67 ± 0.21 | 16.05 ± 0.58 |
| Peak HR (b.p.m.) | 151.31 ± 0.34 | 149.51 ± 0.69 | 146.56 ± 0.72 | 139.70 ± 1.63 |
| HR at VT (b.p.m.) | 114.01 ± 0.35 | 112.53 ± 0.71 | 117.57 ± 0.66 | 116.64 ± 1.75 |
| Peak SBP (mmHg) | 174.81 ± 0.45 | 172.67 ± 0.94 | 159.14 ± 0.95 | 149.19 ± 2.15 |
| Peak DBP (mmHg) | 82.27 ± 0.22 | 82.22 ± 0.45 | 78.36 ± 0.47 | 77.59 ± 1.08 |
| Peak RER (units) | 1.158 ± 0.002 | 1.136 ± 0.003 | 1.135 ± 0.004 | 1.107 ± 0.008 |
| Peak RPE (units) | 18.03 ± 0.05 | 17.89 ± 0.12 | 17.54 ± 0.08 | 16.97 ± 0.20 |
| Characteristics . | No COPD–no HF (Group 1) . | COPD–no HF (Group 2) . | HF–no COPD (Group 3) . | COPD–HF (Group 4) . |
|---|---|---|---|---|
| Baseline parameters | ||||
| HR (b.p.m.) | 72.30 ± 0.23 | 72.36 ± 0.46 | 71.90 ± 0.48 | 73.61 ± 1.09 |
| SBP (mmHg) | 124.77 ± 0.30 | 125.67 ± 0.59 | 120.33 ± 0.62 | 118.08 ± 1.40 |
| DBP (mmHg) | 78.16 ± 0.18 | 77.20 ± 0.36 | 75.25 ± 0.39 | 74.17 ± 0.94 |
| Pulmonary parameters | ||||
| FEV1 (L) | 3.06 ± 0.01 | 2.50 ± 0.02 | 2.85 ± 0.02 | 2.17 ± 0.05 |
| FVC (L) | 3.78 ± 0.01 | 3.93 ± 0.03 | 3.53 ± 0.03 | 3.36 ± 0.06 |
| FEV1/FVC (%) | 0.809 ± 0.001 | 0.638 ± 0.002 | 0.809 ± 0.002 | 0.640 ± 0.005 |
| Exercise parameters | ||||
| ET (min) | 9.47 ± 0.06 | 8.94 ± 0.13 | 9.67 ± 0.10 | 8.89 ± 0.23 |
| VT (mL/min/kg) | 15.15 ± 0.10 | 15.04 ± 0.20 | 16.67 ± 0.21 | 16.05 ± 0.58 |
| Peak HR (b.p.m.) | 151.31 ± 0.34 | 149.51 ± 0.69 | 146.56 ± 0.72 | 139.70 ± 1.63 |
| HR at VT (b.p.m.) | 114.01 ± 0.35 | 112.53 ± 0.71 | 117.57 ± 0.66 | 116.64 ± 1.75 |
| Peak SBP (mmHg) | 174.81 ± 0.45 | 172.67 ± 0.94 | 159.14 ± 0.95 | 149.19 ± 2.15 |
| Peak DBP (mmHg) | 82.27 ± 0.22 | 82.22 ± 0.45 | 78.36 ± 0.47 | 77.59 ± 1.08 |
| Peak RER (units) | 1.158 ± 0.002 | 1.136 ± 0.003 | 1.135 ± 0.004 | 1.107 ± 0.008 |
| Peak RPE (units) | 18.03 ± 0.05 | 17.89 ± 0.12 | 17.54 ± 0.08 | 16.97 ± 0.20 |
DBP, diastolic blood pressure; ET, exercise time; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; HR, heart rate; MI, myocardial infection; PCI, percutaneous coronary intervention; RER, respiratory exchange ratio; RPE, rate of perceived exertion; SBP, systolic blood pressure; VT, ventilatory threshold. Continuous parameters are expressed as means ± SD and categorical parameters as counts (percentages).
Resting haemodynamics, exercise parameters, and pulmonary function data for the study population
| Characteristics . | No COPD–no HF (Group 1) . | COPD–no HF (Group 2) . | HF–no COPD (Group 3) . | COPD–HF (Group 4) . |
|---|---|---|---|---|
| Baseline parameters | ||||
| HR (b.p.m.) | 72.30 ± 0.23 | 72.36 ± 0.46 | 71.90 ± 0.48 | 73.61 ± 1.09 |
| SBP (mmHg) | 124.77 ± 0.30 | 125.67 ± 0.59 | 120.33 ± 0.62 | 118.08 ± 1.40 |
| DBP (mmHg) | 78.16 ± 0.18 | 77.20 ± 0.36 | 75.25 ± 0.39 | 74.17 ± 0.94 |
| Pulmonary parameters | ||||
| FEV1 (L) | 3.06 ± 0.01 | 2.50 ± 0.02 | 2.85 ± 0.02 | 2.17 ± 0.05 |
| FVC (L) | 3.78 ± 0.01 | 3.93 ± 0.03 | 3.53 ± 0.03 | 3.36 ± 0.06 |
| FEV1/FVC (%) | 0.809 ± 0.001 | 0.638 ± 0.002 | 0.809 ± 0.002 | 0.640 ± 0.005 |
| Exercise parameters | ||||
| ET (min) | 9.47 ± 0.06 | 8.94 ± 0.13 | 9.67 ± 0.10 | 8.89 ± 0.23 |
| VT (mL/min/kg) | 15.15 ± 0.10 | 15.04 ± 0.20 | 16.67 ± 0.21 | 16.05 ± 0.58 |
| Peak HR (b.p.m.) | 151.31 ± 0.34 | 149.51 ± 0.69 | 146.56 ± 0.72 | 139.70 ± 1.63 |
| HR at VT (b.p.m.) | 114.01 ± 0.35 | 112.53 ± 0.71 | 117.57 ± 0.66 | 116.64 ± 1.75 |
| Peak SBP (mmHg) | 174.81 ± 0.45 | 172.67 ± 0.94 | 159.14 ± 0.95 | 149.19 ± 2.15 |
| Peak DBP (mmHg) | 82.27 ± 0.22 | 82.22 ± 0.45 | 78.36 ± 0.47 | 77.59 ± 1.08 |
| Peak RER (units) | 1.158 ± 0.002 | 1.136 ± 0.003 | 1.135 ± 0.004 | 1.107 ± 0.008 |
| Peak RPE (units) | 18.03 ± 0.05 | 17.89 ± 0.12 | 17.54 ± 0.08 | 16.97 ± 0.20 |
| Characteristics . | No COPD–no HF (Group 1) . | COPD–no HF (Group 2) . | HF–no COPD (Group 3) . | COPD–HF (Group 4) . |
|---|---|---|---|---|
| Baseline parameters | ||||
| HR (b.p.m.) | 72.30 ± 0.23 | 72.36 ± 0.46 | 71.90 ± 0.48 | 73.61 ± 1.09 |
| SBP (mmHg) | 124.77 ± 0.30 | 125.67 ± 0.59 | 120.33 ± 0.62 | 118.08 ± 1.40 |
| DBP (mmHg) | 78.16 ± 0.18 | 77.20 ± 0.36 | 75.25 ± 0.39 | 74.17 ± 0.94 |
| Pulmonary parameters | ||||
| FEV1 (L) | 3.06 ± 0.01 | 2.50 ± 0.02 | 2.85 ± 0.02 | 2.17 ± 0.05 |
| FVC (L) | 3.78 ± 0.01 | 3.93 ± 0.03 | 3.53 ± 0.03 | 3.36 ± 0.06 |
| FEV1/FVC (%) | 0.809 ± 0.001 | 0.638 ± 0.002 | 0.809 ± 0.002 | 0.640 ± 0.005 |
| Exercise parameters | ||||
| ET (min) | 9.47 ± 0.06 | 8.94 ± 0.13 | 9.67 ± 0.10 | 8.89 ± 0.23 |
| VT (mL/min/kg) | 15.15 ± 0.10 | 15.04 ± 0.20 | 16.67 ± 0.21 | 16.05 ± 0.58 |
| Peak HR (b.p.m.) | 151.31 ± 0.34 | 149.51 ± 0.69 | 146.56 ± 0.72 | 139.70 ± 1.63 |
| HR at VT (b.p.m.) | 114.01 ± 0.35 | 112.53 ± 0.71 | 117.57 ± 0.66 | 116.64 ± 1.75 |
| Peak SBP (mmHg) | 174.81 ± 0.45 | 172.67 ± 0.94 | 159.14 ± 0.95 | 149.19 ± 2.15 |
| Peak DBP (mmHg) | 82.27 ± 0.22 | 82.22 ± 0.45 | 78.36 ± 0.47 | 77.59 ± 1.08 |
| Peak RER (units) | 1.158 ± 0.002 | 1.136 ± 0.003 | 1.135 ± 0.004 | 1.107 ± 0.008 |
| Peak RPE (units) | 18.03 ± 0.05 | 17.89 ± 0.12 | 17.54 ± 0.08 | 16.97 ± 0.20 |
DBP, diastolic blood pressure; ET, exercise time; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; HR, heart rate; MI, myocardial infection; PCI, percutaneous coronary intervention; RER, respiratory exchange ratio; RPE, rate of perceived exertion; SBP, systolic blood pressure; VT, ventilatory threshold. Continuous parameters are expressed as means ± SD and categorical parameters as counts (percentages).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
